WO2019096054A1 - Méthode de criblage d'une lignée cellulaire hek293 déficiente en glutamine synthétase - Google Patents
Méthode de criblage d'une lignée cellulaire hek293 déficiente en glutamine synthétase Download PDFInfo
- Publication number
- WO2019096054A1 WO2019096054A1 PCT/CN2018/114518 CN2018114518W WO2019096054A1 WO 2019096054 A1 WO2019096054 A1 WO 2019096054A1 CN 2018114518 W CN2018114518 W CN 2018114518W WO 2019096054 A1 WO2019096054 A1 WO 2019096054A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene
- screening
- hek293
- sequence
- glutamine
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Definitions
- the sgRNA sequence is one selected from the group consisting of the 5' end extension or the 3' end extension or the 1-5 base sequence of the sequence shown in SEQ ID NO. 2-82.
- the reagents involved in the examples of the present invention are all commercially available products, which are all commercially available. All restriction enzymes were purchased from NEB; DMEM medium was purchased from Thermo; non-essential amino acid mixture was purchased from Thermo: 11140076; 0.1 mM glutamine CDM (Hyclone: SH30858.02) was purchased from Hyclone MSX was purchased from Sigma: M5379-500.
- the PCR reaction was carried out using KAPA HiFi DNA Polymerase at an annealing temperature of 58 ° C for 15 s.
- the recovered EGFP1 fragment and pShCMV-MCS (the MCS sequence is shown in SEQ ID NO. 83, the plasmid map is shown in Figure 13).
- the plasmid was digested with ClaI, BamHI, purified by gel, T4 DNA ligase linkage, DH5 ⁇ competent state. Cell transformation and plasmid DNA miniprep and identification The pShCMV-EGx-MCS plasmid was constructed.
- #2B4 and #3D6 were grown as above to a 60 mm culture dish to nearly 100% overfill.
- the cells were scraped with a cell scraper and centrifuged to remove the supernatant. Resuspend the cells to 500 ⁇ l lysis buffer (100 mM NaCl, 10 mM Tris-Cl (pH 8.0), 25 mM EDTA (pH 8.0), 0.5% SDS, 0.2 mg/ml proteinaseK and 100 ⁇ g/ml RNaseA) at 55 ° C incubator Incubate for 2 hours. After the reaction, the genomic DNA was purified by a phenol chloroform DNA extraction method.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne une lignée cellulaire à base de cellules HEK293 déficiente en glutamine synthétase HEK293-GS-/-qui peut être passée de manière stable, adaptée à une culture en suspension, et peut être appliquée à l'expression de protéines recombinantes construite à l'aide d'un système CRISPR/Cas9. La lignée cellulaire peut exprimer diverses protéines recombinantes par criblage à l'aide d'un système de criblage GS/MSX, peut exprimer de façon stable une protéine cible après de multiples passages, et peut s'adapter à la plupart des milieux sans sérum disponibles dans le commerce.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711122567.6 | 2017-11-14 | ||
CN201711122567.6A CN107893073B (zh) | 2017-11-14 | 2017-11-14 | 一种筛选谷氨酰胺合成酶缺陷型hek293细胞株的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019096054A1 true WO2019096054A1 (fr) | 2019-05-23 |
Family
ID=61805163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2018/114518 WO2019096054A1 (fr) | 2017-11-14 | 2018-11-08 | Méthode de criblage d'une lignée cellulaire hek293 déficiente en glutamine synthétase |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN107893073B (fr) |
WO (1) | WO2019096054A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107893073B (zh) * | 2017-11-14 | 2020-06-02 | 深圳市深研生物科技有限公司 | 一种筛选谷氨酰胺合成酶缺陷型hek293细胞株的方法 |
AU2020274339C1 (en) | 2019-05-13 | 2023-08-31 | Dna Twopointo Inc. | Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products |
CN110551693A (zh) * | 2019-07-22 | 2019-12-10 | 佛山普津生物技术有限公司 | 抗生素筛选hek细胞的方法 |
CN113088497A (zh) * | 2021-04-22 | 2021-07-09 | 河南农业大学 | 一种稳定敲除abhd16a基因的HEK293细胞系及其构建方法 |
CN114107426B (zh) * | 2021-11-10 | 2023-01-06 | 苏州大学 | 一种筛选谷氨酰胺转运蛋白抑制剂的方法、采用该方法筛选出的抑制剂及其应用 |
CN117568402A (zh) * | 2023-11-21 | 2024-02-20 | 上海澳斯康生物制药有限公司 | 一种谷氨酰胺合成酶缺陷型cho细胞系及其制备方法与应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105523969A (zh) * | 2015-12-30 | 2016-04-27 | 北京大学 | 抑制心肌细胞程序性坏死的CaMKII的抑制剂及用途 |
US9567578B1 (en) * | 2016-01-04 | 2017-02-14 | Korea Advanced Institute Of Science And Technology | Cell line containing a knockout of the glutamine synthetase (GS) gene and a method of producing target proteins using a GS knockout HEK293 cell line |
CN107893073A (zh) * | 2017-11-14 | 2018-04-10 | 深圳市港科深研生物科技有限公司 | 一种筛选谷氨酰胺合成酶缺陷型hek293细胞株的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106636154B (zh) * | 2015-10-30 | 2020-09-22 | 中国科学院上海营养与健康研究所 | sgRNA筛选系统和方法 |
-
2017
- 2017-11-14 CN CN201711122567.6A patent/CN107893073B/zh active Active
-
2018
- 2018-11-08 WO PCT/CN2018/114518 patent/WO2019096054A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105523969A (zh) * | 2015-12-30 | 2016-04-27 | 北京大学 | 抑制心肌细胞程序性坏死的CaMKII的抑制剂及用途 |
US9567578B1 (en) * | 2016-01-04 | 2017-02-14 | Korea Advanced Institute Of Science And Technology | Cell line containing a knockout of the glutamine synthetase (GS) gene and a method of producing target proteins using a GS knockout HEK293 cell line |
CN107893073A (zh) * | 2017-11-14 | 2018-04-10 | 深圳市港科深研生物科技有限公司 | 一种筛选谷氨酰胺合成酶缺陷型hek293细胞株的方法 |
Non-Patent Citations (1)
Title |
---|
FAN, LIANCHUN ET AL.: "Improving the Efficiency of CHO Cell Line Generation Using Glutamine Synthetase Gene Knockout Cells", BIOTECHNOLOGY AND BIOENGINEERING, vol. 109, no. 4, 30 April 2012 (2012-04-30), XP055213290, ISSN: 0006-3592, DOI: doi:10.1002/bit.24365 * |
Also Published As
Publication number | Publication date |
---|---|
CN107893073B (zh) | 2020-06-02 |
CN107893073A (zh) | 2018-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2019096054A1 (fr) | Méthode de criblage d'une lignée cellulaire hek293 déficiente en glutamine synthétase | |
TWI747808B (zh) | 新穎之cho整合位點及其用途 | |
US11905521B2 (en) | Methods and systems for targeted gene manipulation | |
US20190271041A1 (en) | Epigenetic modification of mammalian genomes using targeted endonucleases | |
JP4489424B2 (ja) | 染色体に基くプラットホーム | |
Balasubramanian et al. | Comparison of three transposons for the generation of highly productive recombinant CHO cell pools and cell lines | |
EP2864489B1 (fr) | Intégration spécifique d'un site | |
CN110300803B (zh) | 提高细胞基因组中同源定向修复(hdr)效率的方法 | |
CN116218836A (zh) | 编辑rna的方法和组合物 | |
Ley et al. | MAR elements and transposons for improved transgene integration and expression | |
WO2008089396A1 (fr) | Compositions et procédés pour la manipulation et la surveillance génétiques de lignées cellulaires | |
WO2018227755A1 (fr) | Système d'édition de base et procédé de réparation spécifique de mutations du gène hbb chez l'homme, kit de réactifs et applications correspondantes | |
WO2019120193A1 (fr) | Systèmes d'édition de gènes à base unique fragmentés et application associée | |
JP2022070950A (ja) | 生合成経路を発現する合成染色体の作成方法及びその使用 | |
WO2023093008A1 (fr) | Site pour l'expression stable de la protéine dans le gène de cellule cho nw_003613781.1, et son utilisation | |
CN114085841B (zh) | 一种cho细胞基因nw_003614092.1内稳定表达蛋白质的位点及其应用 | |
WO2023093005A1 (fr) | Site capable d'exprimer de manière stable une protéine dans le gène de cellule cho nw_003613756,1 et son utilisation | |
WO2023093007A1 (fr) | Site pour l'expression stable de la protéine dans le gène de la cellule cho nw_003614889.1, et son utilisation | |
JP7472167B2 (ja) | 安定的な標的組み込み | |
CN115698301A (zh) | 活性dna转座子系统及其使用方法 | |
US20200123576A1 (en) | Platform for developing stable mammalian cell lines | |
WO2023050169A1 (fr) | Procédé pour réaliser la conversion de marqueurs en taa sur le génome à haut débit | |
WO2023050158A1 (fr) | Procédé pour réaliser une édition sur plusieurs bases | |
CN110804626B (zh) | 高cg片段与低cg启动子联用构建高效表达载体的方法 | |
Balasubramanian | Study of transposon-mediated cell pool and cell line generation in CHO cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18879303 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18879303 Country of ref document: EP Kind code of ref document: A1 |